案例报告:三例针对固体瘤的全源性CIK疗法.
Yanfei Li1, Xianwu Wang1, Lili Yao1
1Cell Therapy Research Center, Xiamen Hong'ai Hospital, Xiamen, China.
Frontiers in immunology
|September 22, 2025
概括
细胞因子诱导杀伤细胞疗法 (CIK) 为那些无法从传统化疗中获益的固体瘤患者提供了安全有效的替代方案. 这种免疫疗法在管理难以治疗的癌症和预防复发方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 辅助化疗对于恶性固体瘤通常是无效的,原因是某些癌症 (如脏,肝脏) 的治疗选择有限,以及患者特定的因素,如年龄,并发症和不良反应.
- 虽然向疗法和免疫检查点抑制剂已推进癌症治疗,但它们的使用受到遗传测试要求,药物耐药性和显著副作用的限制.
- 由细胞因子诱导的杀伤细胞 (CIK) 治疗,包括注入激活的T细胞,提供了一个更安全的替代方案,具有有利的副作用,显示出消除微转移和预防瘤复发的潜力.
研究的目的:
- 为了评估细胞因子诱导杀伤细胞 (CIK) 细胞治疗在患有恶性固体瘤的患者,不符合或不响应常规化疗的疗效.
- 突出CIK细胞治疗作为各种固体恶性瘤的辅助治疗的潜在好处.
主要方法:
- 这项研究介绍了三项先进固体瘤 (脏恶性瘤,胃癌,肝细胞癌) 患者的病例研究,这些患者没有接受标准化疗.
- 所有患者都接受了细胞因子诱导杀手 (CIK) 细胞疗法.
- 根据患者对CIK细胞治疗的反应来评估结果.
主要成果:
- 这三名患有恶性固体瘤的患者,包括那些化学疗法选择有限,化学疗法不耐受或化学疗法失败的患者,都对CIK细胞治疗表现出了积极的反应.
- 病例1 (脏恶性瘤) 和病例3 (肝细胞癌) 尽管缺乏有效的化疗方案,但仍显示出益处.
- 病例2 (晚期胃癌) 在因副作用的担忧而拒绝化疗后,受益于CIK细胞治疗.
结论:
- 细胞因子诱导的杀伤细胞疗法 (CIK) 建议在固体瘤患者的早期术后应用.
- 它对缺乏有效化疗的癌症类型的患者,对化疗不耐受的人,化疗失败的病例和化疗后放射治疗患者特别有益.
- CIK细胞疗法代表了一种有前途的免疫治疗方法,用于管理固体瘤并改善患者的治疗结果.
相关概念视频
02:49Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K